Literature DB >> 20828854

Access to care and medicines, burden of health care expenditures, and risk protection: results from the World Health Survey.

Anita K Wagner1, Amy Johnson Graves, Sheila K Reiss, Robert Lecates, Fang Zhang, Dennis Ross-Degnan.   

Abstract

OBJECTIVES: We assessed the contribution of health insurance and a functioning public sector to access to care and medicines and household economic burden.
METHODS: We used descriptive and logistic regression analyses on 2002/3 World Health Survey data in 70 countries.
RESULTS: Across countries, 286,803 households and 276,362 respondents contributed data. More than 90% of households had access to acute care. However, less than half of respondents with a chronic condition reported access. In 51 low and middle income countries (LMIC), health care expenditures accounted for 13-32% of total 4-week household expenditures. One in four poor households in low income countries incurred potentially catastrophic health care expenses and more than 40% used savings, borrowed money, or sold assets to pay for care. Between 41% and 56% of households in LMIC spent 100% of health care expenditures on medicines. Health insurance and a functioning public sector were both associated with better access to care and lower risk of economic burden.
CONCLUSION: To improve access, policy makers should improve public sector provision of care, increase health insurance coverage, and expand medicines benefit policies in health insurance systems.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 20828854     DOI: 10.1016/j.healthpol.2010.08.004

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  57 in total

1.  The global cancer epidemic: opportunities for Canada in low- and middle-income countries.

Authors:  Ophira M Ginsburg; Timothy P Hanna; Theodore Vandenberg; Anil A Joy; Mark Clemons; Melaku Game; Ronald Maccormick; Lorraine M Elit; Barry Rosen; Yasmin Rahim; William Geddie; Simon B Sutcliffe; Mary Gospodarowicz
Journal:  CMAJ       Date:  2012-04-10       Impact factor: 8.262

2.  Does health insurance mitigate inequities in non-communicable disease treatment? Evidence from 48 low- and middle-income countries.

Authors:  Abdulrahman M El-Sayed; Anton Palma; Lynn P Freedman; Margaret E Kruk
Journal:  Health Policy       Date:  2015-07-29       Impact factor: 2.980

3.  Pharmaceutical policies used by private health insurance companies in Saudi Arabia.

Authors:  Saleh A Bawazir; Mohammed A Alkudsi; Abdullah S Al Humaidan; Maher A Al Jaser; Larry D Sasich
Journal:  Saudi Pharm J       Date:  2012-11-12       Impact factor: 4.330

Review 4.  Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review.

Authors:  Bonny Parkinson; Catherine Sermet; Fiona Clement; Steffan Crausaz; Brian Godman; Sarah Garner; Moni Choudhury; Sallie-Anne Pearson; Rosalie Viney; Ruth Lopert; Adam G Elshaug
Journal:  Pharmacoeconomics       Date:  2015-09       Impact factor: 4.981

Review 5.  Personal health technology: A new era in cardiovascular disease prevention.

Authors:  Nina C Franklin; Carl J Lavie; Ross A Arena
Journal:  Postgrad Med       Date:  2015-02-18       Impact factor: 3.840

6.  Medicines as a Service: A New Commercial Model for Big Pharma in the Postblockbuster World.

Authors:  Soeren Mattke; Lisa Klautzer; Tewodaj Mengistu
Journal:  Rand Health Q       Date:  2012-06-01

7.  Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries.

Authors:  Catherine E Vialle-Valentin; Brian Serumaga; Anita K Wagner; Dennis Ross-Degnan
Journal:  Health Policy Plan       Date:  2014-09-24       Impact factor: 3.344

8.  Stakeholder perspectives on the challenges surrounding management and supply of essential medicines.

Authors:  Mai H Duong; Rebekah J Moles; Betty Chaar; Timothy F Chen
Journal:  Int J Clin Pharm       Date:  2019-08-23

9.  Mobile Health Devices as Tools for Worldwide Cardiovascular Risk Reduction and Disease Management.

Authors:  John D Piette; Justin List; Gurpreet K Rana; Whitney Townsend; Dana Striplin; Michele Heisler
Journal:  Circulation       Date:  2015-11-24       Impact factor: 29.690

Review 10.  Essential medicines for universal health coverage.

Authors:  Veronika J Wirtz; Hans V Hogerzeil; Andrew L Gray; Maryam Bigdeli; Cornelis P de Joncheere; Margaret A Ewen; Martha Gyansa-Lutterodt; Sun Jing; Vera L Luiza; Regina M Mbindyo; Helene Möller; Corrina Moucheraud; Bernard Pécoul; Lembit Rägo; Arash Rashidian; Dennis Ross-Degnan; Peter N Stephens; Yot Teerawattananon; Ellen F M 't Hoen; Anita K Wagner; Prashant Yadav; Michael R Reich
Journal:  Lancet       Date:  2016-11-08       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.